Highline Wealth Partners’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.8K | Sell |
175
-50
| -22% | -$5.37K | 0.01% | 232 |
|
|
2025
Q1 | $22.7K | Buy |
225
+82
| +57% | +$8.27K | 0.01% | 192 |
|
|
2024
Q4 | $12.8K | Buy |
143
+13
| +10% | +$1.16K | ﹤0.01% | 214 |
|
|
2024
Q3 | $10.9K | Buy |
130
+46
| +55% | +$3.86K | ﹤0.01% | 242 |
|
|
2024
Q2 | $6.47K | Buy |
84
+14
| +20% | +$1.08K | ﹤0.01% | 262 |
|
|
2024
Q1 | $4.79K | Hold |
70
| – | – | ﹤0.01% | 275 |
|
|
2023
Q4 | $4.05K | Hold |
70
| – | – | ﹤0.01% | 257 |
|
|
2023
Q3 | $3.7K | Hold |
70
| – | – | ﹤0.01% | 239 |
|
|
2023
Q2 | $3.79K | Hold |
70
| – | – | ﹤0.01% | 191 |
|
|
2023
Q1 | $3.5K | Hold |
70
| – | – | ﹤0.01% | 193 |
|
|
2022
Q4 | $3.24K | Hold |
70
| – | – | ﹤0.01% | 191 |
|
|
2022
Q3 | $2.71K | Buy |
+70
| New | +$2.71K | ﹤0.01% | 196 |
|